Covista Common Shares (CVSA) closed at $126.50 on October 28, 2026, down 2.1% from the previous close, on volume of 309,562 shares (30-day average 314,737).
Data as of October 28, 2026.
28-Oct-2026
Covista Q1 2027 Earnings Preview
Seeking Alpha News (Wed, 28-Oct 5:35 PM ET)
Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
Business Wire (Tue, 27-Oct 9:00 AM ET)
Wall Street Analysts Are Bullish on Top Consumer Goods Picks
TipRanks (Mon, 26-Oct 12:01 PM ET)
Business Wire (Thu, 22-Oct 5:30 PM ET)
Business Wire (Tue, 13-Oct 6:00 AM ET)
The DAISY Foundation Names Walden University an Extraordinary Educational Partner
Business Wire (Thu, 1-Oct 8:00 AM ET)
Covista Announces First Quarter Fiscal Year 2027 Conference Call
Business Wire (Tue, 29-Sep 8:08 AM ET)
The Healthcare Workforce Gap Is Set to Nearly Double by 2040
Business Wire (Mon, 28-Sep 5:00 AM ET)
Business Wire (Tue, 15-Sep 10:19 AM ET)
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
Covista Common Shares trades on the NYSE stock market under the symbol CVSA.
As of October 28, 2026, CVSA stock price declined to $126.50 with 309,562 million shares trading.
CVSA has a beta of 0.28, meaning it tends to be less sensitive to market movements. CVSA has a correlation of 0.01 to the broad based SPY ETF.
CVSA has a market cap of $4.30 billion. This is considered a Mid Cap stock.
Last quarter Covista Common Shares reported $501 million in Revenue and $2.09 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.20.
The top ETF exchange traded funds that CVSA belongs to (by Net Assets): IJR, VTI, IWM, VB, DFAT.
CVSA support price is $126.83 and resistance is $131.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVSA shares will trade within this expected range on the day.
